| |
| |
|
| Insider
Information: |
Coughlin Christopher J |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
342,599 |
|
|
Indirect Shares
|
17,342 |
|
|
| Direct
Value |
$12,307,323 |
|
|
|
Indirect Value
|
$3,201,457 |
|
|
| Total
Shares |
359,941 |
|
|
| Total
Value |
$15,508,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -5.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JCI |
Johnson Controls Internat... |
Exec. Vice President and CFO |
• – – |
2005-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
100,000 |
|
- |
|
| JCI |
Johnson Controls Internat... |
Exec. Vice President and CFO |
• – – |
2005-11-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
170,000 |
|
- |
|
| IPG |
Interpublic Group of Comp... |
CFO and COO |
• • – |
2004-05-18 |
4 |
A |
$14.06 |
$749,989 |
D/D |
53,342 |
81,842 |
|
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(49,475) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,347) |
0 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
Exec. Vice President and CFO |
• – – |
2005-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2013-02-05 |
4 |
S |
$62.05 |
$2,233,800 |
I/I |
(36,000) |
0 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2013-02-05 |
4 |
OE |
$36.99 |
$1,537,138 |
I/I |
36,000 |
36,000 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2010-11-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,470 |
98,439 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2009-11-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,847 |
76,757 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2008-11-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,350 |
62,568 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,532) |
0 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2008-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,417 |
49,829 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2010-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,354 |
82,010 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-04-29 |
4 |
B |
$81.37 |
$976,440 |
D/D |
12,000 |
15,865 |
2.39 |
% |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2009-11-21 |
4 |
D |
$36.60 |
$369,697 |
D/D |
(10,101) |
66,656 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,009) |
16,542 |
0 |
- |
|
| JCI |
Johnson Controls Internat... |
Exec. Vice President and CFO |
• – – |
2005-08-05 |
4 |
B |
$27.24 |
$272,400 |
D/D |
10,000 |
110,000 |
2.74 |
- |
|
| JCI |
Johnson Controls Internat... |
Exec. Vice President and CFO |
• – – |
2006-02-21 |
4 |
B |
$25.53 |
$255,376 |
D/D |
10,000 |
180,000 |
2.74 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-12-05 |
4 |
A |
$112.75 |
$1,127,500 |
D/D |
10,000 |
16,333 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-12-05 |
4 |
B |
$163.30 |
$1,633,000 |
D/D |
10,000 |
14,446 |
2.39 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
4,446 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2018-04-30 |
4 |
B |
$120.79 |
$1,207,900 |
D/D |
10,000 |
26,333 |
2.39 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-09-06 |
4 |
B |
$190.55 |
$1,906,394 |
D/D |
10,000 |
16,431 |
2.39 |
- |
|
| JCI |
Johnson Controls Internat... |
EVP and CFO |
• – – |
2010-11-21 |
4 |
D |
$37.65 |
$374,643 |
D/D |
(9,952) |
88,487 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
